Skip to content

Prospective observational study of newly emerging venous thromboembolism after vascular reconstruction with allogeneic vessels

Prospective observational study of newly emerging venous thromboembolism after vascular reconstruction with allogeneic vessels

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066264
Enrollment
Unknown
Registered
2022-11-29
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous thromboembolism

Interventions

Vascular reconstruction with allogeneic vessels group:None

Sponsors

Beijing Chao-Yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1)Age between 18 to 75 year-old with no limitation to gender.(2)Preoperative imaging examination indicated no important abdominal vein invasion. (3) Preoperative imaging examination indicated no important abdominal arteries invasion including celiac axis, superior mesenteric artery. (4) Preoperative evaluation indicated no distant metastasis. (5) Preoperative evaluation indicated no contraindication of surgery. (6) PS score between 1 to 2. (7)Preoperative estimated survival time exceed 6 months. (8) Patients and their family members agreed with the protocol and signed informed consent form

Exclusion criteria

Exclusion criteria: (1) Preoperative examination indicated a preoperative VTE. (2) Detected of distant metastasis during surgery and gave up radical operation intraoperatively. (3) Detected of invasion to important abdominal arteries like celiac axis and superior mesenteric artery and gave up radical operation intraoperatively. (4) No indication of the application of allogeneic vessels intraoperatively. (5)Patients and their families refused the study protocol and asked to withdraw.

Design outcomes

Primary

MeasureTime frame
Venous thrombosis;

Secondary

MeasureTime frame
D-dimer;

Countries

China

Contacts

Public ContactHe Qiang

Beijing Chao-Yang Hospital, Capital Medical University

heqiang349@sina.com+86 10 85231504

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026